Quantcast
Channel: sitagliptin
Browsing latest articles
Browse All 2 View Live

Merck Stands Behind the Safety Profile of JANUVIA® (sitagliptin)

WHITEHOUSE STATION, N.J., March 14, 2013 – Merck, known as MSD outside the United States and Canada, today issued the following statement in response to a communication from the U.S. Food and Drug...

View Article



Merck Provides Update on Combination Medicine JUVISYNC™ (sitagliptin and...

News Organization: Merck News Organization Location: WHITEHOUSE STATION, N.J. Merck, known as MSD outside the United States and Canada, today said that the company will voluntarily discontinue...

View Article
Browsing latest articles
Browse All 2 View Live




Latest Images